Tumor-Tropic Stem Cells for Effective Cancer Treatment & Recovery

Cell-based cancer treatments such as NK cell therapy can offer an alternative to standard cancer care, which includes surgery, chemotherapy, radiation therapy and approved immunotherapies chosen by an oncologist. Research into CD4+ T-lymphocyte regeneration for non-Hodgkin lymphoma is ongoing, and it does not replace standard treatment.

Immunotherapy – Treat Cancer without Chemo

▶Immunotherapy for Cancer

CAR T-cell therapy

Our immune system constantly works to identify and monitor all bodily substances, ensuring that anything foreign or harmful, such as bacteria, viruses, or mutated cells, is promptly dealt with. When a new, unfamiliar substance is detected, it triggers an immune response, raising an internal alarm that signals the body to attack and eliminate the invader. However, cancer cells can sometimes evade this natural defense mechanism by mimicking normal cells or creating an environment that suppresses immune responses, allowing them to grow unchecked.

Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in cancer treatment by enhancing the body’s ability to recognize and attack cancer cells. This innovative therapy involves extracting a patient’s T cells, a type of white blood cell that plays a crucial role in immune defense, and genetically modifying them in a laboratory to recognize cancer cells better. The modification process equips T cells with a synthetic receptor, a chimeric antigen receptor (CAR), specifically designed to target proteins on the surface of cancer cells. Once reprogrammed, the enhanced T cells are multiplied and reintroduced into the patient’s bloodstream.

These modified T cells, now equipped with the CAR, can actively seek out cancer cells throughout the body, bind to them, and initiate a potent immune attack that destroys the malignant cells. Unlike traditional cancer treatments such as chemotherapy or radiation, which can also harm healthy tissues, CAR T-cell therapy targets a specific protein on cancer cells. Because some healthy cells carry the same protein, CAR T-cell therapy can still affect normal cells, such as healthy B cells, and it has its own serious side effects.

Moreover, CAR T-cell therapy is a form of cell-based gene therapy because it alters the genetic makeup of the patient’s immune cells. By reprogramming these cells, the therapy can harness the immune system’s power to fight cancer more efficiently and enduringly. In some cases, these modified T cells can remain in the body long after the initial treatment, which may help lower the risk of the cancer returning in some patients, although relapse can still occur. As a result, CAR T-cell therapy holds significant promise for patients with certain types of cancer, especially those who have been resistant to conventional treatments. However, the therapy is not without risks, including potential side effects such as cytokine release syndrome and neurotoxicity, which require careful monitoring and management during treatment.

Stem Cells & Treating Cancer

Stem cell transplantation is used today as part of treatment for some cancers. Gene Therapies such as CAR T-cell therapy and stem cell transplantation are used in standard care for a limited number of cancers, mainly blood cancers such as non-Hodgkin lymphoma, leukemia and multiple myeloma, while senolytic therapies are still being studied and are not an established cancer treatment. In the two main types of blood cancers, lymphoma and leukemia, children or adults may be given high-dose chemotherapy, sometimes with radiation, to eradicate as many cancer cells as possible. This treatment also destroys the bone marrow that produces the blood cells the body needs to recover, and a stem cell transplant is used to restore the marrow afterwards. To overcome this obstacle, oncologists have been using injections of umbilical cord blood or placenta-derived stem cells from otherwise healthy donors to allow the body to recover as it naturally should have the bone marrow still viable. These implanted stem cells are usually injected into the patient’s veins, similar to blood transfusions. Once the enhanced cells and stem cell secretomes are engrafted into the body, they return to the patient’s bone marrow and quickly produce healthy hematopoietic blood cells. This process is not recommended for everyone and may cause other complications for patients with late stages or other underlying diseases that will affect cell therapy for cancer. Is cancer considered an autoimmune disease?

Candidates for Lymphocyte Restoration

Patients who may be evaluated for our cancer treatment protocol, alongside their oncologist’s standard care, include those with the conditions below. Evidence for cell-based treatment is strongest for some blood cancers, and for solid tumors such as lung, liver, colorectal, prostate and pancreatic cancer these approaches remain investigational. Conditions we review include:

• • Relapsed Hodgkin lymphoma
  • Relapsed or high-risk non-Hodgkin’s lymphoma
  • Large B-cell lymphoma is likely to come back
  • Non-responsive cancer/lymphoma
  • Relapsed testicular cancer
  • Modified Immunotherapy for Lung Cancer

• Multiple myelomas
• Treatment for Liver cancer
• Acute leukemia
• Colorectal cancer (CRC)
• Treatment for Prostate cancer
• Treatment of pancreatic cancer

Modified Immune Cells to Fight Cancer – 2026

Watch video

The Two Types of Cells Used in Cancer Remediation:

• Autologous stem cells for cancer come from your own body. Usually via Peripheral Blood stem cells, Bone marrow stem cells, dental pulp stem cells, and adipose fat stem cells.

• Allogeneic stem cells for cancer come from blood-matched or family donors. (Not from your own body) Allogeneic stem cell transplants are most commonly used to treat certain types of cancers, lymphomas, leukemia, and bone marrow disorders such as myelodysplasia. ^[1]

Targeted and Individualized Treatment Planning

Watch video

Stem Cell Collection and Expansion

Your specific protocol will depend on your current diagnosed needs. Typically, stem cell treatments for cancer require a multidisciplinary approach coordinated with the patient’s oncologist, and outcomes depend on the cancer type, stage and the patient’s overall health.

Depending on your needs, we offer a few solutions to treat cancers with and without the need for just Chemotherapy, including:

1. High Intensity Focused Ultrasound (HIFU), a non-radiation treatment that uses focused ultrasound to heat and destroy targeted tissue
2. Lymphocyte Regeneration using Hematopoietic stem cells ^[2]
3. A combination of both plus other treatments such as Monoclonal antibody therapy and steroids
4. Proton Beam Therapy

High-dose Stem Cell Transplants

The Regeneration Center offers a unique cancer treatment that requires cell collection for 2 or 3 days to ensure our doctors can obtain sufficient cells of the required types. Collecting the stem cells requires 1 to 3 hours per visit.

The collection requires no surgery or anesthesia and is generally non-invasive [3]. If your blood work and cell counting (flow cytometer) don’t show enough quantities of the needed types of stem cells, you may need injections of G-CSF, which prompt the bone marrow to release more stem cells into the bloodstream so they can be collected from the blood without iliac crest extractions from the bone marrow. We also offer stem cell banking for up to 25 years. Stored cells have no proven use in treating future brain strokes or heart attacks, which need urgent standard emergency care.^[4]

enlargement

Cancer Immunotherapy Program Costs in 2026

All cancer treatment protocols require a minimum of 14-30 nights in Bangkok. Due to the varying degrees/stages of Illness, our medical team and oncologist will need to better understand the potential patient’s condition before acceptance into the program.

To determine eligibility for treatment and get therapy recommendations with fixed-cost treatment plans, our medical team will need to better understand the patient’s existing needs via recent histological results, Biopsies, DNA Tests, blood tests, x-rays, scans, bone marrow sample results, or clinical diagnosis from your oncologist in your home country.

Upon acceptance, specifics relating to the treatment will be provided, including the total number of nights required and the medical-related costs (excluding accommodations or flights). The exact prices for the stem cell cancer protocol will include all the hospital fees, stem cell extraction and expansion fees, doctor fees, and follow-up consultations for 12 months after treatment.

To learn more or apply for our cancer treatment program, which is designed to work alongside your oncologist’s care, please contact us Today.

Published Clinical Citations

[1] ^ Kheansaard, Wasinee, Sumana Mas-Oo-di, Surasak Nilganuwong, and Dalina I Tanyong. 2012. Interferon-gamma induced nitric oxide-mediated apoptosis of anemia of chronic disease in rheumatoid arthritis. Rheumatology international, no. 1 (January 19). doi:10.1007/s00296-011-2307-y. https://www.ncbi.nlm.nih.gov/pubmed/22258456

[2] ^ Sadler, Nicole M, Britney R Harris, Brittany A Metzger, and Julia Kirshner. 2013. N-cadherin impedes proliferation of the multiple myeloma cancer stem cells. American journal of blood research, no. 4 (December 18). https://www.ncbi.nlm.nih.gov/pubmed/24396705

[3] ^ Snyder, Joshua C, Lauren K Rochelle, Larry S Barak, and Marc G Caron. 2013. The stem cell-expressed receptor Lgr5 possesses canonical and functionally active molecular determinants critical to β-arrestin-2 recruitment. PloS one, no. 12 (December 27). doi:10.1371/journal.pone.0084476. https://www.ncbi.nlm.nih.gov/pubmed/24386388

[4] ^ Subbiah, Vivek, Robert E Brown, Mary F McGuire, Jamie Buryanek, Filip Janku, Anas Younes, and David Hong. 2014. A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin’s lymphoma. Oncotarget, no. 1 ( 15). https://www.ncbi.nlm.nih.gov/pubmed/24395633

Explore our oncology care hub for a wider view of cancer treatment options.